Reduces post-meal glucagon secretion similarly to amylins native function
10.3390/ijms231710135 [DOI] [PMC free article] [PubMed] [Google Scholar] Kong Y.-X., Li Z.-S., Liu Y.-B., Pan B., Fu X., Xiao R., et al
The findings may reflect limitations in dose or treatment duration rather than a definitive lack of efficacy
nasca, c., xenos, d., barone, y., caruso, a., scaccianoce, s., & matrisciano, f
Follow-on clinical research building on the 2020 spicule-plus-exosome photoaging study, extending results beyond mouse models into human trials
Recent regulatory guidance documents, such as the 2025 Australian Therapeutic Goods Administration (TGA) guidance on the quality of listed probiotic medicines and broader discussions on LBPs from 2020, underscore the necessity for strain-level identification, validated enumeration techniques, and explicit labeling of potency and storage conditions (570, 571)